A cocktail of two monoclonal antibodies — casirivimab and imdevimab — significantly reduced the risk for hospitalization or death in nonhospitalized patients with COVID-19, according to results of a phase 3 pivotal trial.Casirivimab with imdevimab (REGEN-COV, Regenerson) also shortened symptom duration and reduced viral load, researchers reported during a breaking news session at the
Patients in rheumatoid arthritis remission who tapered off conventional synthetic disease-modifying antirheumatic drugs had higher risks for flares, with two methods failing to reach non-inferiority…
Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic…
SAN DIEGO — Researchers have developed a new tool to assess malnutrition in children with end-stage kidney disease to help prevent protein-energy wasting, according…
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Alice T. Epitropoulos, MD, FACS, discusses Vevye, a cyclosporine solution that treats signs and…
In a 3-2 vote, the Federal Trade Commission passed a final rule that bans new noncompete agreements with all workers in for-profit organizations. For existing…
Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers…
ATLANTA — Adults genetically predisposed to high stress are more likely to have a heart attack during times of heightened stress, such as a major…
Find allergy and asthma news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.
DENVER — For those experiencing chronic migraine, the presence of self-reported psychiatric conditions did not affect the effectiveness of eptinezumab, according to a poster at…
Adults with low-risk papillary thyroid cancer reported low levels of decision regret for their disease management choice at 1 year, regardless of whether they chose…
